| Description | Sincalide (CCK-8) is a cholecystokinetic drug administered by injection to aid in diagnosing disorders of the gallbladder and pancreas. It is the 8-amino acid C-terminal fragment of cholecystokinin. |
| Synonyms | SQ19844, 辛卡利特, CCK-8, Cholecystokinin octapeptide |
| molecular weight | 1143.27 |
| Molecular formula | C49H62N10O16S3 |
| CAS | 25126-32-3 |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility | H2O: < 0.1 mg/mL (insoluble) DMF: 50 mg/mL (43.73 mM), Sonication is recommended. |
| References | 1. Maher KA et al. Kinevac (sincalide for injection)/Squibb Diagnostics. Gastroenterol Nurs. 1991 Oct;14(2):98-100. |
| Citations | 1. Zang Y, Tian Z, Wang D, et al.METTL3-mediated N6-methyladenosine modification of STAT5A promotes gastric cancer progression by regulating KLF4.Oncogene.2024: 1-17. |